GlassScriptPhysician profile
Blake Thomas Beasley
NPI 1225793359
$991.56
in general payments reported to CMS, 2019-2025
16 companies · $23.00 in 2025
The $23.00 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $310 · 2023: $407 · 2024: $252 · 2025: $23.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $681.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $148.42 | 2023 | Remede System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2022 | |
| Medtronic, INC. | $117.14 | 2022 | |
| Novartis Pharmaceuticals Corporation | $114.82 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $109.12 | 2023-2024 | Farxiga |
| Janssen Pharmaceuticals, INC | $63.43 | 2023-2024 | Xarelto |
| Pfizer INC. | $51.15 | 2023-2024 | |
| Bardy Diagnostics, INC. | $50.00 | 2022 | |
| Novo Nordisk INC | $43.01 | 2024 | Ozempic |
| Biotronik INC. | $40.50 | 2022-2025 | Biomonitor |
| Scpharmaceuticals INC. | $38.10 | 2024 | |
| Esperion Therapeutics, INC. | $28.02 | 2024 | Nexletol |
| Boston Scientific Corporation | $22.96 | 2023 | Watchman Flx |
| Amgen INC. | $15.10 | 2024 | Repatha |
| Baxter Healthcare | $13.30 | 2023 | Hillrom - Carnation Ambulatory Monitor |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acarix USA INC. | $11.49 | 2023 | Cadscor System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Beasley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.